Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02337686
Brief Title: Pembrolizumab in Treating Patients With Recurrent Glioblastoma

First Submitted : January 8, 2015
First Submitted that Met QC Criteria : January 8, 2015
First Posted : January 14, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 7, 2019
Last Update Posted : May 9, 2019